📰 Cachexia Sarcopenia News
Page 2 - Cachexia Sarcopenia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cachexia Sarcopenia. Real-time updates on events, politics, business and more.
May 4, 2022
Provides extended UK patent coverage relating to lead compound S-pindolol benzoate (ACM-001.1) to 2040. International patent application also filed in March 2021. LONDON, May 4, 2022 /PRNewswire/
December 14, 2021
- Actimed Therapeutics initiates the company's first clinical study of the pharmacokinetics and pharmacodynamics (PK/PD) for a new salt of S-pindolol (ACM-001.1) - This study is a prelude
December 14, 2021
/PRNewswire/ -- Actimed Therapeutics Ltd announces that following regulatory approval from the UK Regulatory Agency, it has commenced a clinical study in...
December 14, 2021
/PRNewswire/ -- Actimed Therapeutics Ltd announces that following regulatory approval from the UK Regulatory Agency, it has commenced a clinical study in...
January 14, 2021
2Centro di Ricerca E. Menni, Fondazione Poliambulanza-Istituto Ospedaliero, Brescia, Italy 3Pluristem Ltd., Haifa, Israel 4Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS, Rome, Italy The COVID-19 pandemic has become a priority in the health systems of all nations worldwide. In fact, there are currently no specific drugs or preventive treatments such as vaccines. The numerous therapies available today aim to counteract the symptoms caused by the viral infection that in some su...